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Abstract
Background: There is increasing recognition of complex interrelations between the endocrine functions of bone and fat
tissues or organs.
Objective: The objective was to describe nonmechanical and mechanical links between metabolic factors, body
composition, and bone with the use of graphical Markov models.
Methods: Seventy postmenopausal womenwith a mean6 SD age of 62.36 3.7 y and bodymass index (in kg/m2) of 24.9
6 3.8 were recruited. Bone outcomes were peripheral quantitative computed tomography measures of the distal and
diaphyseal tibia, cross-sectional area (CSA), volumetric bone mineral density (vBMD), and cortical CSA. Biomarkers of
osteoblast and adipocyte function were plasma concentrations of leptin, adiponectin, osteocalcin, undercarboxylated
osteocalcin (UCOC), and phylloquinone. Body composition measurements were lean and percent fat mass, which were
derived with the use of a 4-compartment model. Sequences of Regressions, a subclass of graphical Markov models, were
used to describe the direct (nonmechanical) and indirect (mechanical) interrelations between metabolic factors and bone
by simultaneously modeling multiple bone outcomes and their relation with biomarker outcomes with lean mass, percent
fat mass, and height as intermediate explanatory variables.
Results: The graphical Markov models showed both direct and indirect associations linking plasma leptin and adiponectin
concentrations with CSA and vBMD. At the distal tibia, lean mass, height, and adiponectin-UCOC interaction were directly
explanatory of CSA (R2 = 0.45); at the diaphysis, lean mass, percent fat mass, leptin, osteocalcin, and age-adiponectin
interaction were directly explanatory of CSA (R2 = 0.49). The regression models exploring direct associations for vBMD
were much weaker, with R2 = 0.15 and 0.18 at the distal and diaphyseal sites, respectively. Lean mass and UCOC were
associated, and the global Markov property of the graph indicated that this association was explained by osteocalcin.
Conclusions: This study, to our knowledge, offers a novel approach to the description of the complex physiological
interrelations between adiponectin, leptin, and osteocalcin and the musculoskeletal system. There may be benefits to
jointly targeting both systems to improve bone health. J Nutr doi: 10.3945/jn.115.224485.
Keywords: peripheral quantitative computed tomography, bone, adiponectin, leptin, osteocalcin,
graphical Markov model, postmenopausal women, fat-free mass, fat mass, BMI
Introduction
The relation between bone metabolism and fat tissue/adipocyte-
derived adipokines is not well understood, nor are any resultant
effects on volumetric bone mineral density (vBMD)7, bone size
[cross-sectional area (CSA)], distribution (e.g., cortical area,
cortical thickness), and estimates of strength (e.g., stress strain
index). Evidence suggests a complex interaction between met-
abolic factors (e.g., leptin, adiponectin, osteocalcin) and me-
chanical loading through muscle force and body weight (1, 2).
Leptin is secreted by adipocytes, and its plasma concen-
tration is positively associated with fat mass; in turn, both
are positively associated with bone mineral density (BMD).
Leptin also acts directly on osteoblasts by upregulating bone
formation (3). In contrast, there is evidence of negative effects
of leptin on bone metabolism via the central nervous system
mechanisms regulating body weight (4–6). Both positive
and negative associations have been reported between leptin
and BMD (7–12).
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Adiponectin is also secreted by adipocytes, and the regulation
of secretion is thought to be primarily related to adipocyte size
and insulin sensitivity (13). Greater plasma concentration of
adiponectin is associated with better insulin sensitivity, lower fat
mass and inflammation, and greater lean mass and muscle
strength (14–16). Better insulin sensitivity, in turn, indirectly
stimulates osteoblast activity (2, 4, 17–19). Adiponectin re-
ceptors are also found on both osteoblasts and osteoclasts,
suggesting direct effects on bone turnover (20–22). In human
studies, negative associations of adiponectin with fat mass,
BMD, and cortical thickness have been reported, and adipo-
nectin has been shown to be a predictor of fracture in men (14,
23–30).
Osteocalcin is a bone matrix protein synthesized in the
osteoblast. Osteocalcin is formed when preosteocalcin under-
goes posttranslational modification, which includes vitamin
K–dependent (phylloquinone or menaquinone) carboxylation
(31). The plasma concentration of osteocalcin is a marker of
bone formation. As a fraction of osteocalcin and undercarboxy-
lated osteocalcin (UCOC) is incorporated into the bone matrix,
the plasma concentration of both may also be influenced by the
rate of bone resorption (19). An increased ratio of circulating
UCOC to osteocalcin has been linked to poor bone health (32).
UCOC may also have an endocrine function and has also been
reported to stimulate adiponectin secretion by adipocytes, but
evidence is inconsistent (18, 19, 33, 34).
Considering the interlinked nature of bone metabolism, fat
and energy metabolism, and body composition, it is complex but
relevant to distinguish between the direct actions of leptin,
adiponectin, and osteocalcin on bone and their indirect actions
via body composition (4, 14, 35). Sequences of Regressions
(36, 37), a subclass of graphical Markov models (38, 39), is a
multivariate statistical technique that extends path analysis and
provides, to our knowledge, a novel strategy for describing
complex interrelations by jointly modeling multiple outcomes
and background factors (40). We hypothesized that there would
be nonmechanical associations of the metabolic factors with
bone size, distribution, and vBMD in addition to the mechanical
effects of loading via fat, lean mass, and height. The primary aim
of this study was to use Sequences of Regressions to simulta-
neously describe the interrelations between metabolic factors
(leptin, adiponectin, and osteocalcin) and bone CSA, cortical
area, and vBMD, measured by peripheral quantitative computed
tomography (pQCT), and whether these were direct through
metabolic pathways or indirect (i.e., mechanical) through
body composition or height. The secondary aimwas to investigate
whether specific associations between metabolic factors, bone,
and body composition were supported by the graphical Markov
model.
Methods
Participants
Seventy white British postmenopausal women residing in Cambridge,
United Kingdom, were selected by the use of a stratified design by age
and BMI (in kg/m2) as defined in the inclusion criteria (41). The
original cross-sectional study was powered to detect a correlation of
0.3 between adiponectin and BMD at 90% power and 0.05
significance level (41). Recruitment was through the Medical Re-
search Council Human Nutrition Research volunteer database and
advertisement in general practitioner clinics, media, and local clubs
and educational establishments. Inclusion criteria were aged between
55 and 70 y, had last menstruated >6 y before recruitment, and BMI
between 18.5 and 35.0. Exclusion criteria were early menopause
(<45 y); had either a hip replacement or other metal implant; had been
diagnosed with osteoporosis, diabetes, or a thyroid condition; or were
taking any of the following medications known to affect BMD:
steroids, statins, cholestyramine, and antacids containing aluminum.
Ethical approval was obtained from the Cambridge Local Research
Ethics Committee. All participants gave written informed consent.
The study was carried out in accordance with the Declaration of
Helsinki.
pQCT
A Stratec XCT-2000 (Stratec Medizintechnik, Pforzheim, Germany)
pQCT scanner was used. Scans of the nondominant tibia and nondom-
inant radius were taken at 2 sites: 1) tibia 4% (distal) and 38%
(diaphysis) and 2) radius 4% (distal) and 33% (diaphysis) (42). At the
distal site, measurements of total and trabecular vBMD (mg/cm3) and
total cross-sectional area (mm2) [cross-sectional bone area of the distal
site (CSA-dis)] were taken. The diaphysis measurements were cortical
vBMD (mg/cm3), cortical area (mm2), total CSA [cross-sectional bone
area of the diaphysis site (CSA-dia)], and stress strain index (SSI) (mm2).
To define the scan sites, a scout view was taken and the reference line
was positioned through the middle of the distal endplate. Scans were
analyzed with the use of the following parameters: distal site—contour
mode 1, peel mode 1, threshold of 180 mg/cm3 and diaphyseal site—
separation mode 1, threshold 710 mg/cm3. Precision (CV%) of duplicate
measurements of the tibia in our center (n = 30 adults) was 1.1%and 1.6%
(distal) and 0.4% and 1.0% (diaphysis) for vBMD and CSA, respectively.
Repeat radius measurement CVs ranged between 1% and 4%.
Assessment of body composition with the use of a
4-compartment model
Fat mass (FM, kg) was calculated by the use of the equations of Fuller
et al. (43), which requires measurements of 4 compartments: total body
water (L), total bone mineral content (kg), total body volume (L), and
body weight (BW, kg). The body volume and BW (mass) variables
function together within the model to provide a measure of density
(mass/volume), which then takes into account the water and mineral
content of the body represented by the other variables. This leaves the fat
and protein compartments to be separated based on assumptions about
their density. In this study, total body water was assessed by deuterium
dilution with the use of isotope ratio MS, bone mineral content by DXA
(Lunar MD machine; GE Lunar Corp.), and body volume and BW were
calculated by air-displacement plethysmography (Bod Pod; Life Mea-
surement Instruments). FM percent [(FM/BW) 3 100] was used as a
measure of adiposity. Fat-free mass was calculated by subtracting FM
from body weight and was an estimate of lean mass.
Biochemistry
A fasting, early morning blood sample was taken on the same day as
bone and body composition measurements, and lithium heparin plasma
was stored at 280C. Plasma total adiponectin (Alpco diagnostics) and
leptin (R&D Systems Europe, Ltd.) concentrations were measured by the
use of sandwich ELISAs. Plasma osteocalcin (1–43) and UCOC
concentrations were measured by automated sandwich chemilumines-
cence assay (Diasorin, Inc.) and radioimmunoassay (UCOC; Takara,
Shuzo Co. Ltd.), respectively. [We were unable to calculate percent
UCOC from the 2 assays used in our analysis because of differences in
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number U105960371), conducted within the core program of the MRC Nutrition and
Bone Health Group at MRC Human Nutrition Research, and by an MRC Career
Development Fellowship (grant G0701642 to IS-T). This is an open access article
distributed under the CC-BY license (http://creativecommons.org/licenses/by/3.0/).
2 Author disclosures: I Solis-Trapala, I Schoenmakers, GR Goldberg, A Prentice, and
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3 Supplemental Methods, Supplemental Table 1, and Supplemental Figures 1 and 2
are available from the ‘‘Online Supporting Material’’ link in the online posting of the
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CSA-dis, cross-sectional bone area of the distal site; FM, fat mass; pQCT, peripheral
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the standardization and sensitivity to circulating fragments (44).]
Phylloquinone was measured by HPLC (Waters 2790/2690; Waters
UK) with fluorescence detection (Waters 474; Waters UK) (45). All
biochemical measurements were performed in duplicate. The intra-assay
CVs for duplicate measurements were 0–5.4% for adiponectin, 3.3% for
leptin, 1.9–11.9% for osteocalcin, 0.2–9.5% for UCOC, and 3.0–8.2%
for phylloquinone. The interassay CVs were 8.6–10.2% for adiponectin,
4.4% for leptin, 4.0–9.8% for osteocalcin, 1.4–7.0% for UCOC, and
8.1–16% for phylloquinone.
Anthropometric measurements
Height was measured in bare feet, to the nearest 0.1 cm, by the use of a
calibrated portable stadiometer (CMS Weighing Equipment Ltd.).
Weight was measured (Bod Pod) to the nearest 0.01 kg while the subject
was in a fasting voided state and wearing a swimsuit, with no jewelry,
watches, or glasses.
Statistical methods
Primary analysis. We used Sequences of Regressions (36, 37), a
graphical Markov model to build a multivariate model for sets of
multiple response variables of bone phenotype (vBMD, CSA, and
cortical area of the tibia), metabolic factors (leptin, osteocalcin,
adiponectin, UCOC, phylloquinone), and body habitus (FM percentage,
lean mass, height). The aim of these models was to statistically describe
the hypothesized interrelations among multiple response variables in a
single model to identify the relevant mechanistic links, rather than to
determine the set of best predictors for each variable as would have been
the case if traditional linear regression was used. The interrelations
among variables were depicted by a regression graph with nodes
representing variables arranged in blocks and connected by arrows or
lines to represent direct and indirect associations, respectively (Supple-
mental Methods). To specify the model, based on our hypotheses, we
defined an a priori order of the variables (Figures 1 and 2) in blocks of
multiple-response variables and age (participant characteristic in the last
box). The blocks of variables were ordered to simultaneously describe
direct associations between bone and metabolic factors that were not
explained by their relation with height, FM percentage, and lean mass.
Such relations were assumed to be reflective of nonmechanical associ-
ations between metabolic factors and bone phenotype. Indirect associ-
ations (i.e., those via lean mass, FM, and height) were also described.
The above model was built by fitting ordered sequences of regression
models for each variable in the blocks of multiple-response variables. A
detailed description of model estimation and interpretation, including
checks for interaction terms and nonlinear effects of explanatory
variables, is provided in the Supplemental Methods. Partial regres-
sion coefficients from the linear least squares regressions were used to
quantify the relative importance of associations depicted by the arrows
in the graph. These could be positive or negative associations for a
positive or negative sign of the partial regression coefficient, respectively.
All variables were transformed to natural logarithms before analysis to
allow interpretation of a partial regression coefficient as a percentage
change in the response variable for a percentage change in the
explanatory variable (46). The nonmechanical and mechanical associ-
ations are reported below as partial regression coefficients (b) and
95% CIs. For ease of interpretation, these associations can be read off
the regression graphs from right (direct or intermediate explanatory
variables) to left (response variables). To aid interpretation of 2-way
interactions, we split the main factors into tertiles to represent low,
medium, and high levels and plotted them against geometric mean values
of the outcome (Figure 3). The level of statistical significance was set at
5%.
Although the model fitting required multiple statistical tests, the
components of the model were carefully chosen to reflect distinctive
relations of interest whose interpretation is of interest on their own.
Therefore, the interpretation of each significance level reported is valid,
and adjustment for multiple testing is not required (47).
Secondary analysis. The regression models describing the association
between any 2 outcome variables in the primary analysis partitioned out
the effects of their combined sets of explanatory variables. The global
Markov property of the fitted regression graphs (Figures 1 and 2) was
used to further investigate the relation between 2 variables of interest
after partitioning out the effects of variables that do not necessarily
include their directly explanatory variables (Supplemental Methods)
(37). The presence of a relation depends on how the 2 variables are
linked through the other variables in the model. To identify the role of
important variables more clearly, we explored whether the data
supported associations between 1) vBMD and plasma leptin and
adiponectin concentrations after partitioning out the effect of only FM
percentage and 2) lean mass with UCOC after partitioning out the
effect of osteocalcin.
Further analyses. Tibia pQCT measures were the primary bone
outcomes because the tibia is weight-bearing and measurements are the
most precise. We replicated the analyses on measurements of the radius
to assess the consistency of our findings. In addition, models were fitted
with and without trabecular vBMD (4% site) and SSI (38% site) to select
the most parsimonious models.
All analyses were performed with the use of the statistical software R
(R Development Core Team). The ‘‘ggm’’ package in R provides tools for
reading interrelations off the graph with the use of the global Markov
property of the graph (48).
Results
Descriptive statistics are given in Table 1, and Table 2 presents a
summary of the sequences of regressions fitted for separate
response variables.
For the distal tibia, the variation in CSA-dis was explained by
a combination of lean mass, height, and plasma concentrations
of adiponectin and UCOC individually and in an interaction
term (coefficient of determination R2 = 0.45). Variation in total
vBMD was explained by adiponectin and phylloquinone con-
centrations (R2 = 0.15). At the tibia diaphysis (38% site),
variation in CSA-dia was explained by lean mass, FM percent-
age, leptin concentration, osteocalcin concentration, and age
and adiponectin, individually and in an interaction term (R2 =
0.49). Variation in cortical area was explained by lean mass and
phylloquinone concentration and age, individually and in an
interaction term (R2 = 0.27). Finally, variation in cortical vBMD
was explained by lean mass and osteocalcin concentration (R2 =
0.18).
For body composition, variation in FM percentage was
explained by leptin concentration (R2 = 0.71), whereas variation
in lean mass was explained by osteocalcin concentration (R2 =
0.09). It is important to remember that relations between
variables contained in the same box are not reported, which is
why the well-known relation between height and lean mass is
not described and why the R2 for lean mass is so low.
The interrelations among all the variables are described in
Figure 1 (tibia 4%, distal) and Figure 2 (tibia 38%, diaphyseal).
Nonmechanical associations. There was a direct, negative
association between leptin and CSA-dia. A 10% greater leptin
concentration was associated with a 0.6% decrease in CSA
(partial regression coefficient, b: 20.06%; 95% CI: 20.11,
20.02). This association was direct (i.e., not explained) by
the relation between leptin and FM percentage.
There was a significant interaction term between plasma
adiponectin concentration and UCOC in the regression model
for CSA-dis. Although the individual partial regression coeffi-
cients are positive for both variables, the interaction term has a
negative coefficient, indicating a reducing effect of UCOC on
the size of the relation between adiponectin and CSA-dis. For
those with the lowest concentration of UCOC, therewas a positive
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relation between adiponectin and CSA and a negative, slightly
weaker, relation for those with the highest concentration of
UCOC (Figure 3A). There was a significant interaction term
between plasma adiponectin concentration and age on CSA-dia,
indicating a reducing effect of age on the size of the relation
between adiponectin and CSA-dia. The estimated geometric
mean of CSA-dia was 10% smaller for participants in the upper
tertile of age (aged >64 y) who had a plasma adiponectin
concentration >10.5 mg/L (the upper tertile of the observed
distribution) than for the group of participants aged <61 y (lower
tertile) with a similar concentration of adiponectin. No relation
was evident for participants with a lower adiponectin concentra-
tion (Figure 3B).
Adiponectin concentration was directly, negatively associ-
ated with vBMD of the distal tibia, which was not explained
by body composition (b: 20.10%; 95% CI: 20.18, 20.02).
Furthermore, the globalMarkov property of the graph indicated a
significant association of plasma concentrations of leptin with
adiponectin and vBMD.
There were significant, direct associations between osteocal-
cin concentration and CSA-dia and cortical vBMD. There was a
direct quadratic association between osteocalcin concentration
and CSA-dia, where CSA-dia was greater in individuals with low
and high osteocalcin concentrations. A 10% greater concentra-
tion of osteocalcin was associated with a 0.3% lower cortical
vBMD (b: 20.03; 95% CI: 20.04, 20.01).
There was a significant interaction between phylloquinone
status and age for cortical area at the diaphyseal tibia. In women
with poorer phylloquinone status, younger participants had a
greater cortical area (i.e., thicker cortices) than older partici-
pants (Figure 3C). In contrast, better phylloquinone status was
associated with a 3% greater cortical area in older participants.
Osteocalcin concentration was directly, negatively associated
with lean mass (b:20.07; 95% CI:20.13,20.02). With the use
of the global Markov property of the graph, the data show that
while lean mass and UCOC were related, their relation was
explained by osteocalcin, because the association disappeared
when the effect of osteocalcin was partitioned out.
Leptin concentration was directly, positively associated with
FM percentage (b: 0.32; 95% CI: 0.27, 0.37).
Mechanical associations. Lean mass was directly, positively
associated with CSA-dia (b: 0.46; 95% CI: 0.17, 0.76), CSA-
dis (b: 0.46; 95% CI: 0.22, 0.71), and cortical area (b: 0.41;
95% CI: 0.17, 0.65) and was directly, negatively associated
with cortical vBMD (b: 20.08; 95% CI: 20.15, 20.01). FM
percentage was directly, positively associated with CSA-dia
(b: 0.12; 95% CI: 0.01, 0.24) but not CSA-dis. Height was
directly, positively associated with CSA-dis (b: 0.92; 95% CI:
0.16, 1.7) and was indirectly associated with vBMD, CSA-
dia, and cortical area through lean mass for the diaphyseal
tibia.
Consistency of results in further analyses. Our findings
reflecting the impact of nonmechanical factors on bone in the
tibia were largely replicated in the radius, a non-weight-bearing
site indicating the consistency of our results (see Supplemental
Table 1, Supplemental Figures 1 and 2).
Inclusion of trabecular vBMD in the graphical Markov
model for the distal tibia (results not shown) made no difference
to interpretation; associations were consistent with those for
total vBMD. Similarly, inclusion of SSI did not change the
interpretation of results for the diaphyseal site; the same patterns
of associations were found for SSI as with CSA-dia.
FIGURE 1 Fitted regression graph for distal tibia phenotype, body habitus, and biochemical markers of bone and fat, based on data from 70
postmenopausal women. In the regression graph, an arrow is present between a response and an explanatory variable if there is a significant
association, controlling for all its remaining regressors. The strength of this association is shown as a partial regression coefficient (95% CI) and P
value. Significant interactions described in Table 2 and Figure 3 and nonlinear relations described in Table 2 are also indicated. A dashed line
connects 2 response variables within the same box if there is a significant association between them, controlling for their combined set of
explanatory variables. UCOC, undercarboxylated osteocalcin; vBMD, volumetric bone mineral density.
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Discussion
We have used, to our knowledge, a novel method of analysis to
describe interrelations in postmenopausal women between
leptin, adiponectin, osteocalcin, and bone after partitioning
out the contribution of body composition. We reported evidence
of direct, negative, and indirect positive, associations between
leptin and CSA. Furthermore, we showed evidence that suggests
a synergy between plasma concentration of adiponectin and
osteocalcin. We also described relations between osteocalcin
concentration and lean mass.
Greater percentage FM and higher leptin concentration
were positively associated with CSA-dia, indicating the effect
of greater adiposity on bone CSA. The direct negative
association between leptin and bone CSA-dia may indicate
the negative effects of leptin on the skeleton via central nervous
system regulation of body weight, which have been demon-
strated in mouse models but not consistently in humans (4–6,
10). One reason for inconsistencies in the literature may be
limitations of data analyses, which may not have provided
information on how the interrelation between FM and leptin
affects the relation with CSA (4). Our modeling approach
enabled the identification of partial direct and indirect relations
between leptin and CSA-dia; the indirect relation was via
FM.
The graphs for both the distal and diaphyseal tibia show
significant associations that remain between leptin and
adiponectin and vBMD after partitioning out the effect of
FM percentage. These results support a potential nonmechanical
role of adipose tissue on vBMD through adipocyte secretion of
adiponectin and leptin and are consistent with previous reports
(7–12, 14, 23, 24, 26, 27).
Our analyses showed a significant interaction between adipo-
nectin and UCOC (distal tibia) or age (diaphyseal tibia). Individ-
uals with higher adiponectin and either lower UCOC or younger
age had greater bone CSA (Figure 3). Other studies have shown
that higher plasma adiponectin concentrations are associated with
better insulin sensitivity, lower FM and inflammation, and greater
lean mass and muscle strength, all of which contribute to a greater
bone CSA (14–16, 49). In contrast, for participants in the lowest
tertile, there is lower bone loading due to low BMI (indicated by
high adiponectin or older age) and consequently a smaller bone
CSA. This phenotype is consistent with studies reporting positive
associations between UCOC or adiponectin and increased risk of
fracture because bones that are narrower in cross section for a given
height are less strong (50).
Osteocalcin was directly, negatively associated with lean
mass. The global Markov property of the graph demonstrated
the consistency of this finding where an association between
UCOC and lean mass existed only in the presence of osteocalcin
in the model. This observation is consistent with previous
findings showing an inverse relation between osteocalcin and
BMI (15).
The predominant directly explanatory variable in the regres-
sion models for bone outcomes was lean mass. Following the
mechanostat theory (51), greater lean mass and, consequently,
body weight would exert greater force on bones, which would
drive increases in bone CSA and cortical CSA to maintain
strength. The negative association between lean mass and
cortical vBMD may be because the cortex is thinner because the
FIGURE 2 Fitted regression graph for diaphyseal tibia phenotype, body habitus, and circulating factors, based on data from 70 postmenopausal
women. In the regression graph, an arrow is present between a response and an explanatory variable if there is a significant association,
controlling for all its remaining regressors. The strength of this association is shown as a partial regression coefficient (95% CI) and P value.
Significant interactions described in Table 2 and Figure 3 and nonlinear relations described in Table 2 are also indicated. A dashed line connects 2
response variables within the same box if there is a significant association between them, controlling for their combined set of explanatory
variables. UCOC, undercarboxylated osteocalcin; vBMD, volumetric bone mineral density.
Metabolic factors, body composition, and bone 5 of 9
 by guest on April 1, 2016
jn.nutrition.org
D
ow
nloaded from
 
bone is bigger and longer (height was associated with cortical
vBMD via lean mass) but needs to remain light while
maintaining strength (52). Height was directly associated with
CSA-dis and not total vBMD, indicating the allometric scaling of
bone where a longer bone requires greater cross section to
maintain strength. The lack of association with distal vBMD
supports the notion that vBMD is governed by factors other than
longitudinal growth (53, 54).
Our findings were largely replicated in the radius (Supple-
mental Table 1, Supplemental Figures 1 and 2). There was
consistency between the tibia and radius for both nonmechan-
ical and mechanical associations. Of note is the presence of
interactions between UCOC and adiponectin at the radius. In
addition, the nonmechanical associations found in the primary
analysis were replicated in a model substituting lean mass with
appendicular skeletal mass estimated by DXA (data not shown).
FIGURE 3 Plots of interactions identified
in the graphical models, based on analysis of
data from 70 postmenopausal women, for
(A) the interaction of adiponectin plasma
concentration and UCOC on distal tibia bone
cross-sectional area, P-interaction = 0.02; (B)
the interaction of adiponectin plasma concen-
tration and age on diaphyseal bone cross-
sectional area, P-interaction = 0.01; and (C) the
interaction of phylloquinone and age on diaphy-
seal tibia bone cortical area, P-interaction =
0.002. The 3 points represent the bone
phenotype geometric mean at different
plasma concentrations of adiponectin and
UCOC (A), age and adiponectin (B), and
age and phylloquinone (C) (data split by tertiles
of the observed distributions). Geometric
means were used because the model esti-
mated means of log-transformed data, which
is equivalent to estimating geometric means
in the original data. CSA, cross-sectional
area; Max, maximum data value; Min, mini-
mum data value; UCOC, undercarboxylated
osteocalcin.
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There are several strengths to this study. The use of inde-
pendent methods (pQCT and Bod Pod) to measure outcomes
and explanatory variables gives confidence that associations
found would not be affected by the technical limitations of
DXA (4, 43). DXA measurements of lean tissue, bone, and fat
are determined from a single scan and are based on assump-
tions of the proportions of fat and lean mass in the soft tissue
overlying bone, leading to an interdependence of measure-
ments. We selected outcomes to provide a combined descrip-
tion of phenotype focusing on bone size, distribution, and
vBMD. Although the population sample was small, it was
carefully selected to represent a wide range of BMIs from
underweight to obese, which increases the precision of the
model parameter estimates. The analysis method used was
designed to describe interrelations between bone, body com-
position, and metabolic factors in one multivariate statistical
model, rather than describing predictive models for single
outcome variables where confounding between explanatory
variables can hamper the interpretation of study results.
Furthermore, the model estimation is straightforward and
transparent because it relies on the estimation of local regression
analyses. This allows an efficient use of the data, provides a better
insight into the interrelations, and allows the identification of
nonlinear relations and checks of model assumptions. In contrast,
structural equation models (55), which is an alternative approach
widely used for generating and exploring new research hypotheses,
can become increasingly complex as the number of parameters
grows, leading to convergence problems and inadmissible solu-
tions (56). Finally, our findings in the tibia were mostly replicated
in the radius (Supplemental Methods), indicating the consistency
of our results.
There are limitations to this study: 1) The study design was
cross-sectional and causality cannot be inferred; larger studies
are required to test the consistency of the relations and
implications for bone health in later life; 2) Graphical Markov
modeling aims to assess whether the data are consistent with
postulated hypotheses reflected by the initial ordering of the
TABLE 1 Descriptive characteristics of the study population of
United Kingdom postmenopausal women1
Variable Values
Age, y 62.3 6 3.7 (55.5–70.9)
Height, m 1.7 6 0.1 (1.5–1.8)
Weight, kg 67.5 6 11.3 (49.2–100.0)
BMI,2 kg/m2 24.9 6 3.8 (17.6–33.3)
Lean mass, kg 47.6 6 4.2 (38–57.5)
Fat mass, % 29.2 6 8.1 (10.9–43.8)
Menopausal age, y 51.6 6 3.9 (41.7–63.5)
Years since menopause, y 10.7 6 5 (3.2–29.2)
Lumbar spine T score3 0.86 6 1.2 (24.0 to 2.2)
Femoral neck T score4 -1.0 6 0.73 (22.4 to 0.90)
4% tibia CSA, mm2 1110 6 121 (866–1440)
4% tibia total BMD, mg/cm3 269 6 35.2 (182–356)
38% tibia CSA, mm2 376 6 37 (296–474)
38% tibia cortical CSA, mm2 253 6 22.6 (203–301)
38% tibia cortical BMD, mg/cm3 1120 6 26.7 (1050–1170)
Plasma total adiponectin, μg/L 9.4 6 3.5 (3.5–20.7)
Plasma leptin, μg/L 18.5 6 15.2 (1.0–87.0)
Plasma osteocalcin, μg/L 21.2 6 7.8 (9.2–43.6)
Plasma UCOC, μg/L 7.4 6 6.9 (1.2–29.6)
Plasma phylloquinone, μg/L 0.8 6 0.7 (0.1–3.6)
1 Values are means 6 SDs (ranges), n = 70. BMD, bone mineral density; CSA, cross-
sectional area; UCOC, undercarboxylated osteocalcin.
2 Of the participants, 63% had a healthy BMI (in kg/m2; 18.5–24.9), 19% were
overweight (BMI 25–29.9), and 16% were obese (BMI $30).
3 n = 68 from DXA (GE Lunar Prodigy) measurement of spine.
4 n = 69 from DXA (GE Lunar Prodigy) measurement of hip.
TABLE 2 Selected regression models from regression graphs describing direct and indirect associations between bone outcomes,
circulating factors, and body composition in 70 postmenopausal women1
Explanatory variables
Dependent variable
Distal tibia2 Diaphyseal tibia3
Cross-sectional area (n = 61) Total vBMD (n = 60) Cross-sectional area (n = 60) Cortical area (n = 62) Cortical vBMD (n = 62)
Adiponectin 0.21 (0.07, 0.35) 20.10 (20.18, 20.02) 4.9 (1.1, 8.7)
UCOC 0.87 (0.15, 1.6)
Adiponectin 3 UCOC 20.10 (20.18, 20.02)
Adiponectin 3 age 21.2 (22.09, 20.3)
Phylloquinone 0.06 (0.01, 0.11) 22.6 (24.2, 21.1)
Phylloquinone squared term 0.03 (0.001, 0.06)
Phylloquinone 3 age 0.64 (0.26, 1.0)
Lean mass 0.46 (0.17, 0.76) 0.46 (0.22, 0.71) 0.41 (0.17, 0.65) 20.08 (20.15, 20.01)
Height 0.92 (0.16, 1.7)
Osteocalcin 21.1 (21.8, 20.3) 20.03 (20.04, 20.01)
Osteocalcin squared term 0.2 (0.06, 0.31)
Age 11 (2.4, 19) 0.27 (20.14, 0.68)
Fat mass percentage 0.12 (0.01, 0.24)
Leptin 20.06 (20.11, 20.02)
R 2 0.45 0.15 0.49 0.27 0.18
1 Partial regression coefficients, b (95% CI), and R2 from the Sequences of Regressions were used to estimate the graphical Markov model. Significance levels were set at P ,
0.05. The regression coefficients can be interpreted as percent differences in the outcome per 1% difference in explanatory variable, holding the other variables fixed. For
example, a 1% difference in lean mass would correspond to a 0.46% difference in bone cross-sectional area. UCOC, undercarboxylated osteocalcin; vBMD, volumetric bone
mineral density.
2 Cross-sectional area and total vBMD were associated after controlling for their combined explanatory variables (results not shown).
3 Cross-sectional area was associated with vBMD and cortical area, but vBMD and cortical area were not associated after controlling for their combined set of explanatory
variables (results not shown).
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variables. As with any method of analysis, it depends on having
considered the most influential biological explanatory variables
at the outset. In this study, we did not have detailed information
of diet or physical activity to include in the model; 3) We do not
knowwhether our results would be confirmed with intact (1–49)
osteocalcin; the osteocalcin assay we used measures the 1–43
osteocalcin molecule, and whether this is an active fragment or a
breakdown product of the larger molecule is currently unknown
(57); 4) There may have been inaccuracy in the cortical vBMD
measurement due to partial volume averaging due to thin
cortices, but measurements were taken at sites where this
should be minimal (58); and 5) We did not have measures of
muscle strength to substantiate our findings with fat-free mass.
In conclusion, our data support previous work showing
the importance of a good metabolic health status and nutrient
intakes for bone health and that there is a need to consider
interactions between bone, fat, and muscle to understand
healthy aging. This article provides a strategy for identifying
these pathways simultaneously, as well as evidence to further
inform future study and intervention designs that may target
together musculoskeletal and metabolic health.
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